Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
Lymphatic Abnormalities
×
Clear all
Filters
3
NCT06239480
2025-07-23
SELVA
Palvella Therapeutics, Inc.
Phase 3
Recruiting
40 enrolled